Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BECTON DICKINSON & CO Director's Dealing 2026

Feb 27, 2026

30003_dirs_2026-02-27_fd25b4bd-ab05-470c-aa37-8f9f7a0c6be4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2026-02-26

Reporting Person: Feld Michael (EVP, Chief Revenue Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-26 Common Stock S 75 $181.84 Disposed 21308 Direct

Footnotes

F1: Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.